Comparing Acalabrutinib and Ibrutinib in the Real World: A Study of 2,509 Patients with Chronic Lymphocytic Leukemia

被引：1
|
作者：
Roeker, Lindsey E. [1 ]
DerSarkissian, Maral [2 ]
Ryan, Kellie J. [3 ]
Chen, Yan [4 ]
Wahlstrom, Svea K. [5 ]
Hakre, Shweta [6 ]
Yu, Louise [2 ]
Guo, Helen [4 ]
Mato, Anthony R. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Anal Grp Inc, Boston, MA USA
[3] AstraZeneca, Global Med Affairs, Gaithersburg, MD USA
[4] Anal Grp, Boston, MA USA
[5] AstraZeneca, US Patient Safety Surveillance, Wilmington, DE USA
[6] AstraZeneca, US Med Affairs, Gaithersburg, MD USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-167213
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4156 / 4158
页数：3
相关论文
共 50 条
  • [31] Acalabrutinib: a real breakthrough in the management of relapsed or refractory chronic lymphocytic leukemia?
    Nsiala, Laly
    Tomowiak, Cecile
    [J]. HEMATOLOGIE, 2020, 26 (03): : 146 - 147
  • [32] Impact of Ibrutinib in Quality of Life (QoL) in Patients with Chronic Lymphocytic Leukemia(CLL): Real World Experience in Argentina
    Mela Osorio, Maria Jose
    Pavlovsky, Astrid
    Pavlovsky, Carolina
    Fernandez, Isolda I.
    Clavijo, Manuela
    Miroli, Augusto
    Sackmann, Federico
    Remaggi, Guillermina
    Ferrari, Luciana C.
    Juni, Mariana
    Sighel, Carolina
    Riddick, Maximiliano
    Arturo Pavlovsky, Miguel
    [J]. BLOOD, 2022, 140 : 12403 - 12404
  • [33] Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia Cells
    Patel, Viralkumar
    Balakrishnan, Kumudha
    Bibikova, Elena
    Ayres, Mary
    Keating, Michael J.
    Wierda, William G.
    Gandhi, Varsha
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3734 - 3743
  • [34] A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia
    Chen, Lisa S.
    Bose, Prithviraj
    Cruz, Nichole D.
    Jiang, Yongying
    Wu, Qi
    Thompson, Philip A.
    Feng, Shuju
    Kroll, Michael H.
    Qiao, Wei
    Huang, Xuelin
    Jain, Nitin
    Wierda, William G.
    Keating, Michael J.
    Gandhi, Varsha
    [J]. BLOOD, 2018, 132 (21) : 2249 - 2259
  • [35] REAL-LIFE EFFECTIVENESS OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Dominguez, L.
    Valera-Rubio, M.
    Madronal, Carrion, I
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S32 - S32
  • [36] New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling
    Cadot, Sarah
    Audebert, Chloe
    Dion, Charlotte
    Ken, Soleakhena
    Dupre, Loic
    Largeaud, Laetitia
    Laurent, Camille
    Ysebaert, Loic
    Crauste, Fabien
    Quillet-Mary, Anne
    [J]. PLOS MEDICINE, 2024, 21 (07)
  • [37] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
    Burger, J. A.
    Tedeschi, A.
    Barr, P. M.
    Robak, T.
    Owen, C.
    Ghia, P.
    Bairey, O.
    Hillmen, P.
    Bartlett, N. L.
    Li, J.
    Simpson, D.
    Grosicki, S.
    Devereux, S.
    McCarthy, H.
    Coutre, S.
    Quach, H.
    Gaidano, G.
    Maslyak, Z.
    Stevens, D. A.
    Janssens, A.
    Offner, F.
    Mayer, J.
    O'Dwyer, M.
    Hellmann, A.
    Schuh, A.
    Siddiqi, T.
    Polliack, A.
    Tam, C. S.
    Suri, D.
    Cheng, M.
    Clow, F.
    Styles, L.
    James, D. F.
    Kipps, T. J.
    Keating, Michael
    Jen, Jie
    Jindra, Pavel
    Simkovic, Martin
    Braester, Andrei
    Ruchlemer, Rosa
    Foa, Roberto
    Semenzato, Gianpietro
    Hawkins, Timothy
    Atanasio, Carolina Moreno
    Demirkan, Fatih
    Kaynar, Leylagul
    Pylypenko, Halyna
    Fox, Christopher
    Thirman, Michael
    Campbell, Philip
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2425 - 2437
  • [38] Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
    Roeker, Lindsey E.
    Yazdy, Maryam Sarraf
    Rhodes, Joanna
    Goodfriend, Julie
    Narkhede, Mayur
    Carver, Joseph
    Mato, Anthony
    [J]. JAMA NETWORK OPEN, 2019, 2 (12) : E1916326
  • [39] Real-world dosing patterns and outcomes in patients with chronic lymphocytic leukemia patients with or without dose adjustment of firstline ibrutinib
    Rogers, Kerry
    Lu, Xiaoxiao
    Edmond, Bruno
    Ding, Zhijie
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Mavani, Heena
    Qureshi, Zaina
    Ghosh, Nilanjan
    [J]. LEUKEMIA & LYMPHOMA, 2023, 64 : S169 - S170
  • [40] Combined Ibrutinib and Venetoclax for Patients With Chronic Lymphocytic Leukemia
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 16 - 17
12345